A somatostatin receptor 1 selective ligand inhibits Ca2+ currents in rat insulinoma 1046-38 cells

FEBS Letters

Volumn 425, Issue 1, 1998, Pages 137-140

  Roosterman, Dirk ^a,b   Glassmeier, Günter ^b   Baumeister, Hans ^a   Scherübl, Hans ^b   Meyerhof, Wolfgang ^a,c  

^a GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c UNIVERSITY OF POTSDAM   (Germany)

Author keywords

Adenylyl cyclase; Ca2+ channel; Insulinoma; Neuropcptide; Receptor; Somatostatin

Indexed keywords

ADENYLATE CYCLASE; CYCLIC AMP; LIGAND; OCTREOTIDE; RECEPTOR SUBTYPE; SOMATOSTATIN RECEPTOR;

ANIMAL CELL; ARTICLE; CALCIUM TRANSPORT; CELL LINE; CONTROLLED STUDY; ENZYME INHIBITION; IN VITRO STUDY; INSULINOMA; NONHUMAN; PATCH CLAMP; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS;

ANIMALS; CALCIUM CHANNEL BLOCKERS; INSULINOMA; MEMBRANE POTENTIALS; RATS; RECEPTORS, SOMATOSTATIN; SOMATOSTATIN; TUMOR CELLS, CULTURED;

ANIMALIA;

EID: 0032549635     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-5793(98)00221-X     Document Type: Article

References (25)

1. Patel, Y.C. and Galanopoulou, A. (1995) in: Somatostatin and its Receptors, Ciba Foundation Symposium 190, pp. 26-50, Wiley, Chichester.
2. Epelbaum J., Dournaud P., Fodor M., Violett C. Crit. Rev. Neurobiol. 8:1994;25-44.
3. Reichlin, S. (1983) in: Brain Peptides (Krieger, D.T., Brownstein, M.J. and Martin, J.B., Eds.) pp. 711-752, Wiley, New York.
4. Reisine T., Bell G.I. Endocr. Rev. 16:1995;427-442.
5. Vanetti M., Kouba M., Wang X., Vogt G., Höllt V. FEBS Lett. 311:1992;290-294.
6. Hoyer D., Lübbert H., Bruns C. Naunyn-Schmiedeberg's Arch. Pharmacol. 350:1994;441-453.
7. Williams A.J., Michel A.D., Feniuk W., Humphrey P.P.A. J. Pharmacol. Exp. Ther. 51:1997;1060-1069.
8. Liapakis G., Hoeger C., Rivier J., Reisine T. J. Pharmacol. Exp. Ther. 276:1996;1089-1094.
9. Coy, D., Taylor, J.E. and Rossowski, W.J. (1997) Yale J. Biol. Med., in press.
10. Vanetti M., Vogt G., Höllt V. FEBS Lett. 331:1993;260-266.
11. Akbar M., Okajima F., Tomura H., Majid M., Yamada Y., Seino S., Kondo Y. FEBS Lett. 348:1994;192-196.
12. Viollet C., Bodenant C., Prunotto C., Roosterman D., Schaefer J., Meyerhof W., Epelbaum J., Vaudry H., Leroux P. J. Neurochem. 68:1997;2263-2272.
13. Hamil O.P., Marty A., Neher E., Sakmann B., Sigworth J.F. Pfluegers Arch. Physiol. 391:1981;85-100.
14. Glassmeier G., Strübing C., Riecken E.-O., Buhr H., Neuhaus P., Ahnert-Hilger G., Wiedenmann B., Scherübl H. Gastroenterology. 113:1997;90-100.
15. Roosterman D., Roth A., Kreienkamp H.-J., Richter D., Meyerhof W. J. Neuroendocrinol. 9:1997;741-751.
16. Degtiar V.E., Wittig B., Schultz G., Kalkbrenner F. FEBS Lett. 380:1996;137-141.
17. Fujii Y., Gonoi T., Yamada Y., Chihara K., Inagaki N., Seino S. FEBS Lett. 355:1994;117-120.
18. Meyerhof W., Paust H.-J., Schönrock C., Richter D. DNA Cell Biol. 10:1991;689-694.
19. Raynor K., Wang H.-L., Dichter M., Reisine T. Mol. Pharmacol. 40:1991;248-253.
20. Liapakis G., Fitzpatrick D., Hoeger C., Rivier J., Vandlen R., Reisine T. J. Biol. Chem. 271:1996;20331-20339.
21. Kaupmann K., Bruns C., Raulf F., Weber H.P., Mattes H., Lübbert H. EMBO J. 14:1995;727-735.
22. Kazmierski, W.M., Ferguson, R.D., Knapp, R.J., Lui, G.K., Yamamura, H.I. and Hruby, V.J. Int. J. Pept. Prot. Res. 39, 401-414.
23. Reubi J.C. Neurosci. Lett. 49:1984;259-263.
24. Raynor K., Reisine T. J. Pharmacol. Exp. Ther. 251:1989;510-517.
25. Hoyer D., Pérez J., Schoeffter P., Langenegger D., Schüpbach E., Kaupmann K., Lübbert H., Bruns C., Reubi J.C. Eur. J. Pharmacol. 289:1995;151-161.